Cargando…
hESC-Derived Dopaminergic Transplants Integrate into Basal Ganglia Circuitry in a Preclinical Model of Parkinson’s Disease
Cell replacement is currently being explored as a therapeutic approach for neurodegenerative disease. Using stem cells as a source, transplantable progenitors can now be generated under conditions compliant with clinical application in patients. In this study, we elucidate factors controlling target...
Autores principales: | Adler, Andrew F., Cardoso, Tiago, Nolbrant, Sara, Mattsson, Bengt, Hoban, Deirdre B., Jarl, Ulla, Wahlestedt, Jenny Nelander, Grealish, Shane, Björklund, Anders, Parmar, Malin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899556/ https://www.ncbi.nlm.nih.gov/pubmed/31553914 http://dx.doi.org/10.1016/j.celrep.2019.08.058 |
Ejemplares similares
-
Target‐specific forebrain projections and appropriate synaptic inputs of hESC‐derived dopamine neurons grafted to the midbrain of parkinsonian rats
por: Cardoso, Tiago, et al.
Publicado: (2018) -
Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD
por: Hoban, Deirdre B., et al.
Publicado: (2020) -
A novel two-factor monosynaptic TRIO tracing method for assessment of circuit integration of hESC-derived dopamine transplants
por: Aldrin-Kirk, Patrick, et al.
Publicado: (2021) -
Deconvolution of spatial sequencing provides accurate characterization of hESC-derived DA transplants in vivo
por: Rájová, Jana, et al.
Publicado: (2023) -
Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson’s Disease
por: Kirkeby, Agnete, et al.
Publicado: (2017)